- Abstract #466, https://ash.confex.com/ash/2016/webprogram/Paper95676.html
- Presenter: Laurent Boissel, PhD, NantKwest, Woburn, MA
- Sunday, December 4, 2016, 5:15 PM, Room 5AB
Valeant, NantKwest and Aralez were among the biotech movers in premarket trading on Tuesday.
The CEO of the cable network owner made either $37.2 million or $44.7 million in 2016, depending on what's counted, which is still down sharply from $156.1 million in 2014.
Sage Therapeutics, Depomed and NantKwest were among the biotech stock movers in premarket trading on Friday.